Mito-LND
| CAS No. | 2361564-49-8 | Cat. No. | BCP42814 |
| Name | Mito-LND | ||
| Synonyms | Mito-Lonidamine; | ||
| Formula | C43H45BrCl2N3OP | M. Wt | 801.63 |
| Description | Mito-LND is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation (OXPHOS). Mito-LND inhibits mitochondrial bioenergetics, stimulates the formation of reactive oxygen species, and induces autophagic cell death in lung cancer cells. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Mitochondrial Metabolism | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.